One-Step Solid-Phase Extraction Procedure for
F 2 -isoprostanes (F 2 -iPs) are a group of prostaglandin-like isomers produced from peroxidized arachidonic acid (AA)-containing phospholipids (1 ) . They are new and important markers of lipid peroxidation in vivo (1 ) . However, their introduction into clinical practice has been limited by the need to extract the compounds from their biologic matrices before analysis by immunologic methods or mass spectrometry. Morrow et al. (2 ) and others (3, 4 ) used multiple steps, including thin-layer chromatography and HPLC, in their purification methods. Apart from being time-consuming, these procedures also led to substantial losses of the target compound. In one study (5 ) , the recovery of a urinary metabolite of iPF 2␣ -III was only 20 -30%. Recently, Nourooz-Zadeh et al. (3 ) , using a reversed-phase C 18 cartridge followed by a normal-phase NH 2 cartridge, reported a recovery of 75% for F 2 -iPs (6 ). However, this procedure is still time-consuming.
In this report, we present a simplified and rapid procedure for extracting F 2 -iPs from biologic samples using an Oasis HLB extraction cartridge (Waters Corporation). This cartridge contains a unique copolymer sorbent with hydrophilic and lipophilic groups in proportions that allow high and reproducible recoveries of acidic, basic, and neutral compounds, whether polar or nonpolar (7 ) .
To study the performance of the Oasis cartridge, we prepared two F 2 -iP samples. The first sample contained F 2 -iPs isomers generated by the free radical oxidation of AA, mainly described by Waugh et al. (8 ) . We placed 300 g of AA in 30 L of ethanol in a 12-mL polypropylene tube. The fatty acid was immediately suspended in 2.91 mL of 10 mmol/L phosphate buffer saline by vortexmixing. We added 30 L of 300 g/L hydrogen peroxide and 30 L of 1 mmol/L ferrous chloride. The resulting solution was mixed gently and incubated at 4°C for 12 h.
The second sample contained total F 2 -iPs present in the whole-blood sample collected from a healthy Chinese male subject. Blood (4 mL) was collected into a lithiumheparin tube containing indomethacin, an inhibitor of cyclooxygenase, at a final concentration of 15 mol/L. The blood tube was centrifuged at 2400g for 10 min at 4°C to separate plasma and erythrocytes. Aliquots of plasma (1 mL) were transferred to Eppendorf tubes containing butylated hydroxytoluene, a scavenger of free radicals, at a final concentration of 20 mol/L. One milliliter of 1 mol/L KOH was added to the Eppendorf tube containing the plasma sample. The plasma sample was hydrolyzed at 40°C for 30 min to release bound (esterified) lipids. At the end of the hydrolysis, 1 mL of 1 mol/L HCl and 2 mL of 100 mmol/L formate buffer (pH 3.0) were added. The sample was centrifuged at 2400g for 10 min; the supernatant was then ready for solid-phase extraction.
iPF 2␣ -III-d 4 (20 L an internal standard at a concentration of 100 g/L in ethanol) was added to each sample. The sample was then applied to an Oasis HLB extraction cartridge preconditioned with methanol and 10 mmol/L formate buffer (pH 3.0). The cartridge was washed with 5 mL of the formate buffer followed by 5 mL of acetonitrile- The pentafluorobenzyl-trimethylsilyl derivatives were reconstituted in 40 L of isooctane and the samples analyzed on a GC8000 series gas chromatograph (in NICI mode) coupled to a MD800 mass spectrometer (Fisons Instruments) using methane as the reagent gas. Chromatography was carried out on an SPB-1701 column (30 m ϫ 0.25 mm; film thickness, 0.25 m; Supelco Inc.) using helium as the carrier gas. Injections (1 L) were performed by an AS800 autosampler (Fisons Instruments). The temperature of the injector was kept at 250°C. The oven temperature was increased from 150°C to 235°C at a rate of 15°C/min, increased from 235°C to 280°C at 10.3°C/min, and then maintained at 280°C for 10 min. The MD800 was programmed for optimal detection with the following settings: electron energy, 70 eV; emission energy, 250 A; ion energy, 1.0 eV; and ion energy ramp, 1.0 mV per atomic mass unit. Selected ion monitoring was performed to monitor the carboxylate anion (MϪ181; loss of ⅐ CH 2 C 6 F 5 ) at ions m/z 569 and 573 for F 2 -iPs and the internal standard, respectively. Peak identification was based on the comparison of the relative retention indices with the internal standard. The concentration of F 2 -iP isomers in the samples was calculated using the ratio of the peak height of m/z 569 to that of m/z 573.
To evaluate the analytical performance of the present method, one of the F 2 -iP isomers, iPF 2␣ -III, was used in the quantification and subsequent calculation of recovery and precision performance. The results and the comparison with the method of Nourooz-Zadeh et al. (3 ) are presented in Table 1 . A recovery of ϳ90% was achieved with our method compared with ϳ70% with the purification method of Nourooz-Zadeh et al. (3 ) with comparable data for intraassay and interassay imprecision and linearity. As shown in Fig. 1 , the Oasis purification procedure led to identical GC-NICI-MS chromatograms for F 2 -iPs in calibration solutions and plasma.
In summary, a substantially improved recovery for isolating F 2 -iPs from biologic matrices can be achieved by our one-step purification procedure compared with previous methods. It is also simpler and takes only one-half the extraction time needed by the two-cartridge method (3 ). The procedure is also well suited as a preparatory step to isolate F 2 -iP isomers in complex tissue matrices before applying specific purification procedures, e.g., immunoaffinity chromatography of iPF 2␣ -III.
